Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
about
TheZisomer of 2,4-diaminofuro[2,3-d]pyrimidine antifolate promotes unusual crystal packing in a human dihydrofolate reductase ternary complexDesign, synthesis, and X-ray crystal structures of 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitorsPreferential selection of isomer binding from chiral mixtures: alternate binding modes observed for theEandZisomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductaseDiscovery of antitubulin agents with antiangiogenic activity as single entities with multitarget chemotherapy potential.Single agents with designed combination chemotherapy potential: synthesis and evaluation of substituted pyrimido[4,5-b]indoles as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents.CoMFA analysis of tgDHFR and rlDHFR based on antifolates with 6-5 fused ring system using the all-orientation search (AOS) routine and a modified cross-validated r(2)-guided region selection (q(2)-GRS) routine and its initial application.The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agentsDesign, synthesis and biological evaluation of substituted pyrrolo[2,3-d]pyrimidines as multiple receptor tyrosine kinase inhibitors and antiangiogenic agentsDiscovery of novel antitumor antimitotic agents that also reverse tumor resistance.Discovery and preclinical evaluation of 7-benzyl-N-(substituted)-pyrrolo[3,2-d]pyrimidin-4-amines as single agents with microtubule targeting effects along with triple-acting angiokinase inhibition as antitumor agents.The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.
P2860
Q27656874-8AAB6AAA-692E-4B0F-A318-C301CDFE7664Q27657423-647AEF7E-D0AC-428E-9663-04FCDBA5DCB2Q27666132-9A87CAF2-013D-4441-8D93-6B824B5F764EQ33636107-216E4083-5FC9-46A5-B24D-C8050314221FQ33675186-F3664CC8-27AC-4F70-81B7-D4AF68E1FE19Q33755029-D2052E38-617B-4490-9ECE-5EE822282065Q33872751-051FC681-2ED8-4EC7-83FD-05450A96B8D2Q36775982-BF8DC52C-F3E4-456B-BABE-645509C32E52Q37380736-FED0B959-46D9-47B4-96A0-63A414B76F15Q38728583-A0A80784-8FFE-48A9-8166-8B3F1A59F297Q38974193-B57BA233-4B2E-454A-80A4-216669956568
P2860
Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Novel 5-substituted, 2,4-diami ...... ogenic and antitumor activity.
@en
type
label
Novel 5-substituted, 2,4-diami ...... ogenic and antitumor activity.
@en
prefLabel
Novel 5-substituted, 2,4-diami ...... ogenic and antitumor activity.
@en
P2093
P1476
Novel 5-substituted, 2,4-diami ...... ogenic and antitumor activity.
@en
P2093
Aleem Gangjee
Dixy W Green
Fu-Tyan Lin
Linda A Warnke
Michael Ihnat
Roy L Kisliuk
Yibin Zeng
P304
P356
10.1016/J.BMC.2005.04.087
P407
P577
2005-09-01T00:00:00Z